2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.
A J DemetrisC BellamyS G HübscherJ O'LearyP S RandhawaS FengD NeilR B ColvinG McCaughanJ J FungA Del BelloF P ReinholtH HagaO AdeyiA J CzajaT SchianoM I FielM L SmithM SebaghR Y TanigawaF YilmazG AlexanderL BaiocchiM BalasubramanianI BatalA K BhanJohn C BucuvalasC T S CerskiF CharlotteM E de VeraM ElMonayeriP FontesE E FurthA S H GouwS Hafezi-BakhtiariJ HartE HonsovaW IsmailT ItohN C JhalaU KhettryG B KlintmalmS KnechtleT KoshibaT KozlowskiC R LassmanJ LerutJ LevitskyL LiciniR LiottaG MazariegosM I MinerviniJ MisdrajiT MohanakumarJ MölneI NasserJ NeubergerM O'NeilO PappoL PetrovicP RuizÖ SağolA Sanchez FueyoE SasatomiA ShakedM ShillerT ShimizuB SisA SonzogniH L StevensonS N ThungG TisoneA C TsamandasA WernersonT WuA ZeeviY ZenPublished in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2016)
The Banff Working Group on Liver Allograft Pathology reviewed and discussed literature evidence regarding antibody-mediated liver allograft rejection at the 11th (Paris, France, June 5-10, 2011), 12th (Comandatuba, Brazil, August 19-23, 2013), and 13th (Vancouver, British Columbia, Canada, October 5-10, 2015) meetings of the Banff Conference on Allograft Pathology. Discussion continued online. The primary goal was to introduce guidelines and consensus criteria for the diagnosis of liver allograft antibody-mediated rejection and provide a comprehensive update of all Banff Schema recommendations. Included are new recommendations for complement component 4d tissue staining and interpretation, staging liver allograft fibrosis, and findings related to immunosuppression minimization. In an effort to create a single reference document, previous unchanged criteria are also included.